Prevention of carrageenan-induced pleurisy in mice by anti-CD30 ligand monoclonal antibody

Rosanna Di Paola; Roberto Di Marco; Emanuela Mazzon; Tiziana Genovese; Klaus Bendtzen; Battesimo Macrì; Ferdinando Nicoletti; Salvatore Cuzzocrea

doi:10.1016/j.clim.2004.05.008

Prevention of carrageenan-induced pleurisy in mice by anti-CD30 ligand monoclonal antibody

Rosanna Di Paola, Roberto Di Marco, Emanuela Mazzon, Tiziana Genovese, Klaus Bendtzen, Battesimo Macrì, Ferdinando Nicoletti, Salvatore Cuzzocrea

IRCCS Centro Neurolesi "Bonino Pulejo"

Research output: Contribution to journal › Article › peer-review

Abstract

CD30 ligand (CD30L) and its receptor CD30 are members of the tumor necrosis factor (TNF) and TNF receptor superfamilies that play a major role in inflammation and immune regulation. To gain insight into the in vivo role of CD30L/CD30 in inflammatory diseases, we have used carrageenan (CAR)-induced pleurisy in mice, a preclinical model of airway inflammation where type 1 proinflammatory cytokines such as interleukin (IL)-1 and TNF-α play a key pathogenic role. The data show that prophylactic treatment with anti-CD30L mAb markedly reduces both laboratory and histological signs of CAR-induced pleurisy. These data suggest involvement of CD30-mediated signals in acute immunoinflammatory pathways induced by CAR.

Original language	English
Pages (from-to)	64-73
Number of pages	10
Journal	Clinical Immunology
Volume	113
Issue number	1
DOIs	https://doi.org/10.1016/j.clim.2004.05.008
Publication status	Published - Oct 2004

Keywords

CD30L
Cytokine
Pleurisy

ASJC Scopus subject areas

Immunology
Immunology and Allergy

Access to Document

10.1016/j.clim.2004.05.008

Fingerprint Dive into the research topics of 'Prevention of carrageenan-induced pleurisy in mice by anti-CD30 ligand monoclonal antibody'. Together they form a unique fingerprint.

Cite this

Prevention of carrageenan-induced pleurisy in mice by anti-CD30 ligand monoclonal antibody. / Di Paola, Rosanna; Di Marco, Roberto; Mazzon, Emanuela; Genovese, Tiziana; Bendtzen, Klaus; Macrì, Battesimo; Nicoletti, Ferdinando; Cuzzocrea, Salvatore.

In: Clinical Immunology, Vol. 113, No. 1, 10.2004, p. 64-73.

Research output: Contribution to journal › Article › peer-review

@article{c141650fa4244fd8b993fcfbf27a920b,

title = "Prevention of carrageenan-induced pleurisy in mice by anti-CD30 ligand monoclonal antibody",

abstract = "CD30 ligand (CD30L) and its receptor CD30 are members of the tumor necrosis factor (TNF) and TNF receptor superfamilies that play a major role in inflammation and immune regulation. To gain insight into the in vivo role of CD30L/CD30 in inflammatory diseases, we have used carrageenan (CAR)-induced pleurisy in mice, a preclinical model of airway inflammation where type 1 proinflammatory cytokines such as interleukin (IL)-1 and TNF-α play a key pathogenic role. The data show that prophylactic treatment with anti-CD30L mAb markedly reduces both laboratory and histological signs of CAR-induced pleurisy. These data suggest involvement of CD30-mediated signals in acute immunoinflammatory pathways induced by CAR.",

keywords = "CD30L, Cytokine, Pleurisy",

author = "{Di Paola}, Rosanna and {Di Marco}, Roberto and Emanuela Mazzon and Tiziana Genovese and Klaus Bendtzen and Battesimo Macr{\`i} and Ferdinando Nicoletti and Salvatore Cuzzocrea",

year = "2004",

month = oct,

doi = "10.1016/j.clim.2004.05.008",

language = "English",

volume = "113",

pages = "64--73",

journal = "Clinical Immunology",

issn = "1521-6616",

publisher = "Academic Press Inc.",

number = "1",

}

TY - JOUR

T1 - Prevention of carrageenan-induced pleurisy in mice by anti-CD30 ligand monoclonal antibody

AU - Di Paola, Rosanna

AU - Di Marco, Roberto

AU - Mazzon, Emanuela

AU - Genovese, Tiziana

AU - Bendtzen, Klaus

AU - Macrì, Battesimo

AU - Nicoletti, Ferdinando

AU - Cuzzocrea, Salvatore

PY - 2004/10

Y1 - 2004/10

N2 - CD30 ligand (CD30L) and its receptor CD30 are members of the tumor necrosis factor (TNF) and TNF receptor superfamilies that play a major role in inflammation and immune regulation. To gain insight into the in vivo role of CD30L/CD30 in inflammatory diseases, we have used carrageenan (CAR)-induced pleurisy in mice, a preclinical model of airway inflammation where type 1 proinflammatory cytokines such as interleukin (IL)-1 and TNF-α play a key pathogenic role. The data show that prophylactic treatment with anti-CD30L mAb markedly reduces both laboratory and histological signs of CAR-induced pleurisy. These data suggest involvement of CD30-mediated signals in acute immunoinflammatory pathways induced by CAR.

AB - CD30 ligand (CD30L) and its receptor CD30 are members of the tumor necrosis factor (TNF) and TNF receptor superfamilies that play a major role in inflammation and immune regulation. To gain insight into the in vivo role of CD30L/CD30 in inflammatory diseases, we have used carrageenan (CAR)-induced pleurisy in mice, a preclinical model of airway inflammation where type 1 proinflammatory cytokines such as interleukin (IL)-1 and TNF-α play a key pathogenic role. The data show that prophylactic treatment with anti-CD30L mAb markedly reduces both laboratory and histological signs of CAR-induced pleurisy. These data suggest involvement of CD30-mediated signals in acute immunoinflammatory pathways induced by CAR.

KW - CD30L

KW - Cytokine

KW - Pleurisy

UR - http://www.scopus.com/inward/record.url?scp=6044241772&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=6044241772&partnerID=8YFLogxK

U2 - 10.1016/j.clim.2004.05.008

DO - 10.1016/j.clim.2004.05.008

M3 - Article

C2 - 15380531

AN - SCOPUS:6044241772

VL - 113

SP - 64

EP - 73

JO - Clinical Immunology

JF - Clinical Immunology

SN - 1521-6616

IS - 1

ER -